Inflammation in COVID-19: A Risk for superinfections
M Boulos, T Bassal, A Layyous, M Basheer, N Assy - COVID, 2022 - mdpi.com
The worldwide coronavirus pandemic has been one of the most significant health crisis
threats in recent years. COVID-19 has not been the only cause of mortality in this pandemic …
threats in recent years. COVID-19 has not been the only cause of mortality in this pandemic …
Bacterial endocarditis following COVID-19 infection: two case reports
E Barahimi, S Defaee, R Shokraei… - Journal of Medical Case …, 2023 - Springer
Background COVID-19, an emerging disease raised as a pandemic, urgently needed
treatment choices. Some options have been confirmed as lifesaving treatments, but long …
treatment choices. Some options have been confirmed as lifesaving treatments, but long …
[HTML][HTML] Ketamine-based sedation use in mechanically ventilated critically ill patients with COVID-19: A multicenter cohort study
Backgrounds Ketamine possesses analgesia, anti-inflammation, anticonvulsant, and
neuroprotection properties. However, the evidence that supports its use in mechanically …
neuroprotection properties. However, the evidence that supports its use in mechanically …
Survival implications vs. complications: unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19—A multicenter cohort study
Background Despite insufficient evidence, vitamin D has been used as adjunctive therapy in
critically ill patients with COVID-19. This study evaluates the effectiveness and safety of …
critically ill patients with COVID-19. This study evaluates the effectiveness and safety of …
[HTML][HTML] When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study
Background Favipiravir is an oral antiviral, that might treat COVID-19 by enhancing viral
eradication, particularly in patients with mild-to-moderate disease. Yet, the findings on the …
eradication, particularly in patients with mild-to-moderate disease. Yet, the findings on the …
Evaluation of early tocilizumab effect on multiorgan dysfunction in critically ill patients with COVID-19: a propensity score-matched study
O Aljuhani, GB Korayem… - Journal of Intensive …, 2023 - journals.sagepub.com
Background: Tocilizumab (TCZ) has been proposed as potential rescue therapy for severe
COVID-19. No previous study has primarily assessed the role of TCZ in preventing severe …
COVID-19. No previous study has primarily assessed the role of TCZ in preventing severe …
The Clinical Manifestation of SARS-CoV-2 in Critically Ill Patients with Klebsiella pneumoniae NDM Hospitalized in the ICU of a Modular Hospital during the Third …
A Guzek, Z Rybicki, A Woźniak-Kosek, D Tomaszewski - Diagnostics, 2022 - mdpi.com
There is limited information on the clinical characteristics of critically ill patients infected with
SARS-CoV-2 and Klebsiella pneumoniae NDM. The objective of this study was to describe …
SARS-CoV-2 and Klebsiella pneumoniae NDM. The objective of this study was to describe …
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Background Previous studies have shown mortality benefits with corticosteroids in
Coronavirus disease-19 (COVID-19). However, there is inconsistency regarding the use of …
Coronavirus disease-19 (COVID-19). However, there is inconsistency regarding the use of …